251 related articles for article (PubMed ID: 27903495)
1. Testosterone treatment and risk of venous thromboembolism: population based case-control study.
Martinez C; Suissa S; Rietbrock S; Katholing A; Freedman B; Cohen AT; Handelsman DJ
BMJ; 2016 Nov; 355():i5968. PubMed ID: 27903495
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study.
Parker C; Coupland C; Hippisley-Cox J
BMJ; 2010 Sep; 341():c4245. PubMed ID: 20858909
[TBL] [Abstract][Full Text] [Related]
3. Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2015 May; 350():h2135. PubMed ID: 26013557
[TBL] [Abstract][Full Text] [Related]
4. Association between Use of Exogenous Testosterone Therapy and Risk of Venous Thrombotic Events among Exogenous Testosterone Treated and Untreated Men with Hypogonadism.
Li H; Benoit K; Wang W; Motsko S
J Urol; 2016 Apr; 195(4 Pt 1):1065-72. PubMed ID: 26523880
[TBL] [Abstract][Full Text] [Related]
5. Risk of Venous Thromboembolism in Men Receiving Testosterone Therapy.
Baillargeon J; Urban RJ; Morgentaler A; Glueck CJ; Baillargeon G; Sharma G; Kuo YF
Mayo Clin Proc; 2015 Aug; 90(8):1038-45. PubMed ID: 26205547
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer.
Martinez C; Cohen AT; Bamber L; Rietbrock S
Thromb Haemost; 2014 Aug; 112(2):255-63. PubMed ID: 24695909
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant drug use and risk of venous thromboembolism.
Jick SS; Li L
Pharmacotherapy; 2008 Feb; 28(2):144-50. PubMed ID: 18225961
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and risk of venous thromboembolism: population based case-control study.
Pérez Gutthann S; García Rodríguez LA; Castellsague J; Duque Oliart A
BMJ; 1997 Mar; 314(7083):796-800. PubMed ID: 9081000
[TBL] [Abstract][Full Text] [Related]
9. Association of Testosterone Therapy With Risk of Venous Thromboembolism Among Men With and Without Hypogonadism.
Walker RF; Zakai NA; MacLehose RF; Cowan LT; Adam TJ; Alonso A; Lutsey PL
JAMA Intern Med; 2020 Feb; 180(2):190-197. PubMed ID: 31710339
[TBL] [Abstract][Full Text] [Related]
10. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study.
Johannesdottir SA; Horváth-Puhó E; Dekkers OM; Cannegieter SC; Jørgensen JO; Ehrenstein V; Vandenbroucke JP; Pedersen L; Sørensen HT
JAMA Intern Med; 2013 May; 173(9):743-52. PubMed ID: 23546607
[TBL] [Abstract][Full Text] [Related]
11. Testosterone therapy and venous thromboembolism: A systematic review and meta-analysis.
Houghton DE; Alsawas M; Barrioneuvo P; Tello M; Farah W; Beuschel B; Prokop LJ; Layton JB; Murad MH; Moll S
Thromb Res; 2018 Dec; 172():94-103. PubMed ID: 30396049
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study.
Sode BF; Dahl M; Nielsen SF; Nordestgaard BG
Am J Respir Crit Care Med; 2010 May; 181(10):1085-92. PubMed ID: 20167844
[TBL] [Abstract][Full Text] [Related]
13. Venous Thromboembolism in a Transgender Adolescent on Testosterone Therapy: A Case Report and Literature Review.
Fan EM; Gordner C; Luty J
J Pediatr Hematol Oncol; 2020 Jul; 42(5):e352-e354. PubMed ID: 32079984
[TBL] [Abstract][Full Text] [Related]
14. Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization.
Holmqvist ME; Neovius M; Eriksson J; Mantel Ä; Wållberg-Jonsson S; Jacobsson LT; Askling J
JAMA; 2012 Oct; 308(13):1350-6. PubMed ID: 23032551
[TBL] [Abstract][Full Text] [Related]
15. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
Dinger J; Assmann A; Möhner S; Minh TD
J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRD.
Ishiguro C; Wang X; Li L; Jick S
Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1168-75. PubMed ID: 25195779
[TBL] [Abstract][Full Text] [Related]
17. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2019 Jan; 364():k4810. PubMed ID: 30626577
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism in patients having knee replacement and receiving thromboprophylaxis: a Danish population-based follow-up study.
Pedersen AB; Mehnert F; Johnsen SP; Husted S; Sorensen HT
J Bone Joint Surg Am; 2011 Jul; 93(14):1281-7. PubMed ID: 21792493
[TBL] [Abstract][Full Text] [Related]
19. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort.
Tagalakis V; Patenaude V; Kahn SR; Suissa S
Am J Med; 2013 Sep; 126(9):832.e13-21. PubMed ID: 23830539
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism in adults screened for sickle cell trait: a population-based cohort study with nested case-control analysis.
Little I; Vinogradova Y; Orton E; Kai J; Qureshi N
BMJ Open; 2017 Mar; 7(3):e012665. PubMed ID: 28360235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
